FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joanne Halsey

Research Profile

Disorders

Chemicals & Drugs

Procedures

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
George A Fisher; Timothy Kuo; Meghan Ramsey; Erich Schwartz; robert rouse; Cheryl D Cho; Joanne Halsey; Branimir I Sikic
A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer.
Cheryl D Cho; George A Fisher; Joanne Halsey; Branimir I Sikic
Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies.
Ranjana Advani; Bert L Lum; George A Fisher; Joanne Halsey; David L Chin; C D Jacobs; Branimir I Sikic
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joanne Halsey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: George A Fisher; Timothy Kuo; Meghan Ramsey; Erich Schwartz; robert rouse; Cheryl D Cho; Joanne Halsey; Branimir I Sikic
A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):7074-9.
2006: Cheryl D Cho; George A Fisher; Joanne Halsey; Branimir I Sikic
Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies.
Investigational new drugs 2006;24(2):117-23.
2005: Ranjana Advani; Bert L Lum; George A Fisher; Joanne Halsey; David L Chin; C D Jacobs; Branimir I Sikic
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(12):1968-73.
2005: Ranjana Advani; Bert L Lum; George A Fisher; Joanne Halsey; Richard S Geary; Jon T Holmlund; T Jesse Kwoh; F Andrew Dorr; Branimir I Sikic
A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer.
Investigational new drugs 2005;23(5):467-77.
2005: Timothy Kuo; Cheryl D Cho; Joanne Halsey; Heather A Wakelee; Ranjana Advani; James M Ford; George A Fisher; Branimir I Sikic
Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5613-9.
2004: Ranjana Advani; Prema P Peethambaram; Bert L Lum; George A Fisher; Lynn Hartmann; Harry J Long; Joanne Halsey; Jon T Holmlund; Andrew Dorr; Branimir I Sikic
A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma.
Cancer 2004;100(2):321-6.
2001: Ranjana Advani; George A Fisher; Bert L Lum; J Hausdorff; Joanne Halsey; Litchman Manuel; Branimir I Sikic
A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1221-9.
1999: Alan R Yuen; Joanne Halsey; George A Fisher; Jon T Holmlund; Richard S Geary; T Jesse Kwoh; Andrew Dorr; Branimir I Sikic
Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3357-63.
1997: Kevin Gang Chen; George A Fisher; Bert L Lum; Joanne Halsey; L Beketic-Oreskovic; G Chen
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Cancer chemotherapy and pharmacology 1997;40 Suppl():S13-9.
1994: N L Bartlett; B L Lum; George A Fisher; N A Brophy; M N Ehsan; Joanne Halsey; Branimir I Sikic
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):835-42.
1994: Branimir I Sikic; George A Fisher; B L Lum; N A Brophy; A M Yahanda; K M Adler; Joanne Halsey
Clinical reversal of multidrug resistance.
Cancer treatment and research 1994;73():149-65.
1993: B L Lum; George A Fisher; N A Brophy; A M Yahanda; K M Adler; S Kaubisch; Joanne Halsey; Branimir I Sikic
Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.
Cancer 1993;72(11 Suppl):3502-14.
1992: B L Lum; S Kaubisch; A M Yahanda; K M Adler; L Jew; M N Ehsan; N A Brophy; Joanne Halsey; M P Gosland; Branimir I Sikic
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1635-42.
1992: A M Yahanda; K M Alder; George A Fisher; N A Brophy; Joanne Halsey; R I Hardy; M P Gosland; B L Lum; Branimir I Sikic
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1624-34.
1991: C Jacobs; S Kaubisch; Joanne Halsey; B L Lum; M Gosland; C Norman Coleman; Branimir I Sikic
The use of probenecid as a chemoprotector against cisplatin nephrotoxicity.
Cancer 1991;67(6):1518-24.
1990: J M Berry; C Jacobs; Branimir I Sikic; Joanne Halsey; R F Borch
Modification of cisplatin toxicity with diethyldithiocarbamate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(9):1585-90.
1990: C Norman Coleman; T H Wasserman; R C Urtasun; Joanne Halsey; L Noll; S Hancock; T L Phillips
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03.
International journal of radiation oncology, biology, physics 1990;18(2):389-93.
1988: C Norman Coleman; R W Carlson; R A Artim; W I Sampson; H J Lawrence; P Wong; Joanne Halsey; M Kohler; M Gribble; Branimir I Sikic
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole.
Cancer research 1988;48(12):3528-32.
1987: C Norman Coleman; Joanne Halsey; R S Cox; V K Hirst; T Blaschke; A E Howes; T H Wasserman; R C Urtasun; T Pajak; S Hancock
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile.
Cancer research 1987;47(1):319-22.
1986: C Norman Coleman; T H Wasserman; R C Urtasun; Joanne Halsey; V K Hirst; S Hancock; T L Phillips
Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule.
International journal of radiation oncology, biology, physics 1986;12(7):1105-8.
1984: C Norman Coleman; R C Urtasun; T H Wasserman; S Hancock; J W Harris; Joanne Halsey; V K Hirst
Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508.
International journal of radiation oncology, biology, physics 1984;10(9):1749-53.
1984: C Norman Coleman; V K Hirst; D M Brown; Joanne Halsey
The effect of vitamin B6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: clinical and laboratory studies.
International journal of radiation oncology, biology, physics 1984;10(8):1381-6.
1984: C Norman Coleman; S C Ballon; A E Howes; A Martinez; Joanne Halsey; V K Hirst
The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
Gynecologic oncology 1984;18(1):18-27.
1983: C Norman Coleman; M K Friedman; C Jacobs; Joanne Halsey; R Ignoffo; S Leibel; V K Hirst; M Gribble; S K Carter; T L Phillips
Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Cancer research 1983;43(10):5022-5.